The Ophthalmologist · March 2023
Deep in Thought Processes
A useful starting point for teams deciding which clinical problem to solve and what evidence to develop.
Read at publisher ↗
Request an introduction SCIENCE · CLINICAL PRACTICE · BUSINESS
Ideas on bringing ophthalmic innovation into practice. Explore articles by Michael Mrochen and collaborators, alongside recorded talks, interviews and independent editorial coverage.
PUBLISHED PERSPECTIVES
The Ophthalmologist · March 2023
A useful starting point for teams deciding which clinical problem to solve and what evidence to develop.
Read at publisher ↗The Ophthalmologist · December 2014
Relevant to development teams assessing whether an existing technology can answer an unmet clinical need.
Read at publisher ↗CRST Europe · February 2016
Relevant to founders, R&D leaders and investors deciding which milestone should come next.
Read at publisher ↗WATCH & LISTEN
Conversations on science, product development and bringing ophthalmic innovation into practice.
FEATURED CONVERSATION · ESCRS · Vimeo
4 September 2025
Jim Mazzo and Michael Mrochen
Why do ophthalmic innovations succeed or stall on the way to market? A conversation bringing together the investor’s perspective and the inventor’s experience.
Watch at source ↗Related reading: Translational Research: Innovate Horizontally
ESCRS iNovation · YouTube
2022 presentation
Michael Mrochen · Allotex
An Allotex presentation on the development of corneal allograft lenticules for presbyopia. This historical recording reflects the programme and development status at the time.
Watch at source ↗Related reading: The Genesis of Allogenic Inlays
ESCRS / EuroTimes Eye Contact · Vimeo
London 2014 · published 29 October 2016
John Marshall and Michael Mrochen · interviewed by Oliver Findl
A discussion of developments and future directions in ophthalmic laser technology, recorded at the ESCRS Congress in London in 2014.
Watch at source ↗Related reading: Deep in Thought Processes
Ophthalmology Futures Forums · Vimeo
Publication date not confirmed
Michael Mrochen · Allotex
A company presentation from the Ophthalmology Futures Forums archive. Included as a historical record of the innovation journey; company status and product information may have changed.
Watch at source ↗Related reading: The Genesis of Allogenic Inlays
Ophthalmology Innovation Source
Historical presentation
Michael Mrochen · ClearSight Innovations
A presentation on ocular biometry and the development of Mirricon for IOL power calculation, illustrating the path from an optical measurement concept toward clinical application.
Watch at source ↗Related reading: From Workbench to Clinical Proof of Concept: Mirricon
Recordings remain with their original publishers. Summaries follow the publishers’ descriptions; historical presentations reflect their original context. Video players load only when selected.
Authored articles, collaborative work and clearly labelled interviews and editorial coverage.
11 articles
Innovation & Commercialization
March 2023
The Ophthalmologist
Coauthored article
Michael Mrochen; Lisa Kleintjens
How medical-device development connects patient needs, clinical practice, technology and market requirements. Drawing on IMCUSTOMEYE, this article examines the work needed to close the gap between research and commercialization.
Why it matters
A useful starting point for teams deciding which clinical problem to solve and what evidence to develop.
Innovation & Commercialization
December 2014
The Ophthalmologist
Coauthored article
Pavel Zakharov; Mark Talary; Daniel Boss; Michael Mrochen
A perspective on bringing technologies from other disciplines into ophthalmology and bridging gaps in medical-device development. The article connects scientific feasibility with clinical needs, practical development expertise and the path to a useful product.
Why it matters
Relevant to development teams assessing whether an existing technology can answer an unmet clinical need.
Innovation & Commercialization
February 2016
CRST Europe
Coauthored article
Michael Mrochen; Ronan Byrne; Arthur B. Cummings
A company-building case study covering the team, development planning and clinical proof behind Mirricon. It describes the relationship between technical achievement, credible clinical evidence and a route to commercialization.
Why it matters
Relevant to founders, R&D leaders and investors deciding which milestone should come next.
Digital Ophthalmology
June 2019
CRST Europe
Authored article
Michael Mrochen
An early perspective on how digital transformation could change ophthalmic decisions, communication and business models. It considers collaboration, data and the practical changes facing clinicians and manufacturers.
Why it matters
Historical perspective on the organizational questions that accompany digital technology adoption.
Practice Strategy
June 2019
CRST Europe
Authored article
Michael Mrochen
A practical discussion of aligning a practice’s marketing with its strategy, culture and target patients. It connects positioning, patient touchpoints and measurement with a clear plan for the team.
Why it matters
Relevant to clinic leaders aligning patient experience and communications with their service offering.
Innovation & Commercialization
February 2015
CRST Europe
Coauthored article
Mark S. Talary; Michael Mrochen
A historical discussion of the European regulatory changes facing ophthalmic device developers in 2015 and their implications for development planning.
Why it matters
Historical context only; this article is not current regulatory guidance.
Clinical Technologies
January 2011
CRST Europe
Expert contribution
Multiple expert contributors, including Michael Mrochen
A multi-expert discussion of the development and future direction of corneal crosslinking, including Michael’s contribution.
Why it matters
An archival view of an evolving technology; clinical statements should be read in their original context.
Clinical Technologies
January 2009
CRST Europe
Authored article
Michael Mrochen
An early article on corneal approaches to presbyopia correction and the optical questions behind them.
Why it matters
Historical technical perspective, not current treatment advice.
Interviews & Coverage
September 2024
The Ophthalmologist
Interview retrospective
Jamie Irvine; interview subject: Michael Mrochen
A retrospective revisiting a 2022 interview about Michael’s career, role models, entrepreneurship and professional networks.
Why it matters
Connects the scientific and entrepreneurial experiences behind IROC Science.
Interviews & Coverage
June 2022
The Ophthalmologist
Quoted contribution
Duncan Welling; includes comments from Michael Mrochen
An editorial exploring how clinical, commercial, technical and entrepreneurial expertise come together. Michael contributes a perspective on collaboration and aligning technologies with patient needs.
Why it matters
Relevant to leadership teams building the right mix of expertise around a development project.
Interviews & Coverage
August 2016
The Ophthalmologist
Quoted contribution
Ruth Steer; includes comments from Michael Mrochen
A historical feature on tissue-based corneal inlays, including perspectives from Michael Mrochen, David Muller and Soosan Jacob.
Why it matters
Documents early thinking on tissue addition; historical development descriptions are not current product claims.